ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GSK Gsk Plc

1,653.00
12.50 (0.76%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  12.50 0.76% 1,653.00 1,654.00 1,655.00 1,655.50 1,634.00 1,638.50 3,990,601 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.83 68.14B

Unilever CMO Keith Weed to Retire -- 2nd Update

06/12/2018 8:43pm

Dow Jones News


Gsk (LSE:GSK)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Gsk Charts.
By Suzanne Vranica 

Unilever Chief Marketing Officer Keith Weed will retire from the company in May, the consumer-products giant said Thursday.

Mr. Weed, 57 years old, has been at Unilever for 35 years. The announcement of his departure comes shortly after the company named Alan Jope to succeed longtime Chief Executive Paul Polman. The company, along with its rivals, faces many challenges, including a shift in consumer tastes.

"I am moving onto another chapter," Mr. Weed said in an interview.

Mr. Weed has been an outspoken marketer for many years and has long advocated for better measurement of digital advertising. He frequently called on digital companies such as Google and Facebook to "stop grading their own homework."

More recently, Mr. Weed began leveraging Unilever's ad spending power to push the digital media industry to weed out content that exploits children, spreads false news, or supports racist and sexist views.

Mr. Weed said he intends to stay active in the industry and continue to push for change.

"The biggest challenge we have is that we need to rebuild trust in advertising," he said. "The industry still needs to work harder" to fix the things that are undermining that trust such as data breaches, the bombardment of ads, fake followers and fake news, he added.

"These issue are all solvable," Mr. Weed said.

Unilever spent more than $9 billion last year marketing its brands such as Lipton, Dove and Knorr, according to the company's annual report.

"I have been privileged to lead some of the best Marketing, Sustainability and Communication teams in the world," Mr. Weed said in a statement. "As the world's second largest advertiser, we have been able to leverage our scale for effectiveness and efficiencies, and we have also been able to leverage our scale for good, leading to greater responsibility, transparency and accountability in the advertising and digital industry."

Mr. Weed's role was increasingly in question at Unilever in recent years, particularly after Unilever found itself on the receiving end of a hostile bid from Kraft Heinz Co., according to people familiar with the matter.

While Mr. Weed led a team that accelerated Unilever's push into digital marketing and is responsible for all Unilever's relationships with agencies, he doesn't control any of the marketing budget for its brands, which is instead controlled by its three division heads, the people said.

One option now, according to one of the people, is for Unilever to scrap the CMO role and instead assign responsibility for the marketing functions to marketing heads within each of its three categories: beauty and personal care, home care, and food and refreshments. The company has a deep bench of people with marketing expertise it could choose from for such roles, the person said.

Unilever has been trying to simplify its way of working to be more agile and responsive, a drive it accelerated after Kraft's approach. Devolving the marketing role could help it delayer and make more locally focused decisions, said this person.

A spokeswoman said the company won't immediately name a successor because the decision will be up to Mr. Jope, who starts as CEO next month.

Mr. Jope has been described by people who have worked with him as a brand builder himself, someone who is likely to be more focused than the departing CEO on Unilever's marketing.

In an internal memo announcing Mr. Weed's retirement, Unilever also said its head of research and development, David Blanchard, was stepping down and will be succeeded by GlaxoSmithKline PLC's head of research and development for consumer health care, Richard Slater. Mr. Blanchard has worked at Unilever since 1986 and had been its R&D chief since 2014.

Write to Suzanne Vranica at suzanne.vranica@wsj.com

 

(END) Dow Jones Newswires

December 06, 2018 15:28 ET (20:28 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

1 Year Gsk Chart

1 Year Gsk Chart

1 Month Gsk Chart

1 Month Gsk Chart

Your Recent History

Delayed Upgrade Clock